Best Disease Self Management Companies in New Jersey, United States
The 74 best Disease Self Management companies in New Jersey, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Valeritas.
Our analysis of 50 Disease Self Management companies
$3.0b in tracked funding; 94% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Disease Self Management companies in New Jersey
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Valeritas Developer of wearable insulin patch pumps for insulin delivery through the skin | $231M | 121 mo ago | Acquired | — | 2003 | — | 212 patents Hydraulic drug delivery systems with needle retraction, timed release, and cartridge integration. | — |
| 2 | Theranica Developer of prescription digital therapeutics for neurological pain management | $86M | 45 mo ago | Series C | Slava Barabash Co Founder and Vice President Research and Development | 2016 | WordPressMySQLPHP+18 | — | — |
| 3 | GlucoTrack Provider of blood glucose monitor for continuous glucose monitoring | $45M | 22 mo ago | Public | David Malka Co-Founder | 2001 | WordPress Block EditorWordPressMySQL+28 | 10 patents Implantable low‑power continuous glucose sensors with rapid response and spinal‑cord stimulation integration | 2 launchs · 1 partnership |
| 4 | Essenlix Provider of mobile health self test platform | $20M | 94 mo ago | Series A | — | 2013 | — | 459 patents Optical and microfluidic biomedical assay platforms for blood and tissue diagnostics | 1 partnership |
| 5 | Jana Care Provider of mobile-based healthcare diagnostics for diabetes prevention 53Innovation top 27%Funding top 30%Product top 32%Moat top 39% All 8 signals ▾Innovationtop 27% Fundingtop 30% Producttop 32% Moattop 39% Markettop 45% Talentbottom 49% Globalbottom 39% Techbottom 22% Innovation: 3 product lines · Deep-tech classification: Tech Hardware Funding: Raised $17.7M across 8 rounds · 8 rounds over 14 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 53/100 | $18M | 3 mo ago | Series C | Anh Hoang Chief Executive Officer | 2011 | — | — | — |
| 6 | Avertix Provider of an implantable heart attack warning system 42Funding top 32%Talent top 38%Moat top 39%Growth top 40% All 8 signals ▾Fundingtop 32% Talenttop 38% Moattop 39% Growthtop 40% Techbottom 48% Marketbottom 32% Globalbottom 32% Newsbottom 22% Funding: Raised $13.8M across 6 rounds · 6 rounds over 3 yrs (2.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 42/100 | $14M | 9 mo ago | Series B | David Fischell Co-Founder | 2001 | Node.jsSalesforceUbuntu+12 | — | — |
| 7 | Snorble Manufacturer of interactive screen free educational devices for young children | $10M | 19 mo ago | Series B | Mike Rizkalla Co-Founder & CEO | 2019 | Cart FunctionalityShopifyYouTube+21 | 4 patents Software for configurable narrative generation and interactive storytelling systems | — |
| 8 | LibAirty Provider of airway clearance system synchronizing controlled breathing with chest compressions 24Funding top 50%Talent bottom 49%Global bottom 36% All 3 signals ▾Fundingtop 50% Talentbottom 49% Globalbottom 36% Funding: Raised $9.3M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 24/100 | $9M | 4 mo ago | Series A | Anat Shani CEO | 2016 | — | — | — |
| 9 | EyeNetra Smartphone-powered vision testing tools for eye care professionals, enabling mobile refraction | $7M | 142 mo ago | Series A | Vitor Pamplona Chief Executive Officer | 2011 | Animate.cssBootstrapVarnish+8 | 13 patents Portable automated refractive measurement and eye relaxation devices using small-aperture lensometers | — |
| 10 | BioStream Technologies Provider of video game based therapy for ASD | $2M | 26 mo ago | Seed | Michael Farber CEO | 2015 | — | 5 patents Patents concentrated in health & consumer products | — |
| 11 | Hale Connected device for smoking cessation | $666K | 16 mo ago | Series A | Josh Israel Co-Founder & CEO | 2018 | — | — | — |
| 12 | OculoMotor Technologies Virtual reality based therapy for binocular vision dysfunctions patients | $225K | 83 mo ago | Funding Raised | Chang Yaramothu Co-Founder & CEO & CTO | 2018 | — | — | — |
| 13 | Synsei Non-invasive device to measure fetal cardiology | $150K | 149 mo ago | Deadpooled | William Braunlin Co-Founder | 2013 | — | — | — |
| 14 | Ovatemp Online platform offering thermometer and app for fertility tracking | $120K | 135 mo ago | Deadpooled | Ana Mayer Co-Founder & Chief Fertility Officer | 2012 | — | 2 patents Portable fertility monitoring devices and related data analysis methods | — |
| 15 | Brainmarc Mobile health platform for monitoring mental activity | $111K | 80 mo ago | Deadpooled | Goded Shahaf Co-Founder | 2013 | — | — | — |
Top 12 Disease Self Management companies in New Jersey
#1
Series C · Newton, New Jersey · founded 2011 · 60 employees$17.7Mraised▾
JanaCare is a healthcare technology startup providing a diagnostic device and a mobile-based platform for diabetes management. The device can measure blood glucose, lipids, creatinine, and hemoglobin. Its Habits program available both on the web and through a mobile application is based on the diabetes prevention program curriculum. The mobile app "food: habits" tracks user's calories and fat intake provides suggestions for meals, aids to set calorie burning and weight loss goals.
- Mar 2026Series C$1.4M
- Mar 2025Series C$2.9M
- Oct 2023Series C$13.1M
- Nov 2022Series B$575.3K
#2
Series A · Jersey City, New Jersey · founded 2016$9.3Mraised▾
Provider of airway clearance system synchronizing controlled breathing with chest compressions. The system facilitates controlled breathing at different lung volumes. Airflow is directed to clear small airways. The system is designed to keep lungs clear of mucus build-up and infections. It aims to reduce symptoms with daily sessions. The device is intended to improve respiratory health and quality of life.
- Feb 2026Series A$5M
- Aug 2025Series A$4.3M
#3
Series B · Eatontown, New Jersey · founded 2001 · 31 employees$13.8Mraised▾
Provider of an implantable heart attack warning system. The company's flagship product is Guardian System an implantable, patient alerting system to warn patients to seek medical attention for Acute Coronary Syndrome (ACS), including silent heart attacks.
- Sep 2025Series B$1M
- Sep 2024Series B$14.3M
- Jul 2024Series A$7.1M
- Oct 2023Conventional Debt$13.5M
#4
Public · Rutherford, New Jersey · founded 2001 · 3 employees$45Mraised▾
Provider of blood glucose monitor for continuous glucose monitoring. It offers an implantable system that continuously measures blood glucose levels with a sensor longevity for people living with diabetes.
- Jul 2024Post IPO$4M
- Apr 2024Post IPO$500K
- Feb 2020Post IPO$15M
- Dec 2017Post IPO$425K
#5
Series B · Montgomery, New Jersey · founded 2019 · 20 employees$10Mraised▾
Manufacturer of interactive screen free educational devices for young children. These hardware products function offline to facilitate routines, sleep habits, and learning activities. The devices utilize voice and touch interaction to provide content focused on social emotional development, language, and cognitive skills. A companion application allows for the scheduling of routines and the selection of content based on developmental stages. The hardware operates without cameras or cloud surveillance to maintain privacy.
- Nov 2024Series B—
- Apr 2022Series B$12.3M
#6
Series C · Bridgewater, New Jersey · founded 2016 · 44 employees$86Mraised▾
Developer of prescription digital therapeutics for neurological pain management. It focuses on creating wearable therapeutic devices intended to improve the quality of life. The company integrates neuroscience research with technological expertise to offer non-invasive, drug-free solutions. It develops products that stimulate peripheral nerves to induce conditioned pain modulation.
- Aug 2022Series C$45M
- Mar 2019Series B$35M
- Jul 2017Series A$6M
- Sep 2016Seed—
#7
Series A · Philadelphia, New Jersey · founded 2018 · 16 employees$665.9Kraised▾
The Hale Vaporizer is a connected device for nicotine de-addiction. The Hale device is a patent-pending device is used to track nicotine usage through an LED strip recorded in the app. It also provides a mobile app to track usage and helps to provide health information. The company claims that the device and formulation are manufactured based on GMP and GLP conditions.
- Feb 2025Grant (prize money)$333K
- Jan 2023Grant (prize money)$333K
- Mar 2022Series A—
#8
Acquired · Bridgewater, New Jersey · founded 2003 · 141 employees$231.4Mraised▾
Developer of wearable insulin patch pumps for insulin delivery through the skin. It offers holds one day's supply of fast-acting insulin and releases it at a continuous preset basal rate and on-demand bolus dosing at mealtimes. Its pump is not programmable and does not use electricity. Its devices are available at a preset basal rate to deliver diverse amounts of insulin in a day and on-demand bolus dosing.
- May 2016Post IPO$25.2M
- Jul 2014Series D$22M
- Jun 2013Conventional Debt$100M
- Sep 2011Series C$150M
#9
Seed · Moorestown, New Jersey · founded 2015 · 7 employees$2Mraised▾
Provider of video game-based therapy for ASD. The platform is developing video game therapy for children with an autism spectrum disorder. The therapy includes animations, music, levels, power-ups, and more.
- Apr 2024Seed$200K
- Feb 2024Seed$150K
- Dec 2022Seed$875K
- Jan 2021Seed$725K
#10
Seed · Princeton, New Jersey · founded 2020 · 31 employees$75Kraised▾
Provider of AI-driven digital therapeutics for women's mental health. It offers digital-first behavioral health solutions supported by health coaches and therapists. These solutions are evidence-based and clinically trial-tested, providing accessible care anytime, anywhere. The platform includes personalized programs addressing various life stages, from fertility to menopause. It utilizes AI-driven predictive algorithms for identification and risk-stratification of mental health disorders. The company also develops and publishes research on its programs.
- Mar 2025Grant (prize money)—
- Aug 2024Seed—
- Feb 2023Grant (prize money)$75K
#11
Series A · Monmouth Junction, New Jersey · founded 2013 · 22 employees$20Mraised▾
Provider of mobile health self-test platform. MOST or Instant Mobile Self-Test, the flagship platform that replaces traditional in-person lab-testing with a mobile phone device. The company used nanotechnology, imaging, and artificial intelligence in its diagnostic testing.
- Aug 2018Series A$20M
#12
Series A · Somerville, New Jersey · founded 2011 · 3 employees$7Mraised▾
Smartphone-powered vision testing tools for eye care professionals, enabling mobile refraction. This company empowers eye care professionals with cutting-edge mobile technology for vision testing anywhere. They offer a suite of devices, including autorefractors, lensometers, and phoropters, designed for accuracy and portability. Their products facilitate mobile refractive clinics, screening events, and workplace testing, enhancing access to vision care. The Insight Portal, a cloud-based EMR solution, streamlines patient management, scheduling, and e-prescriptions. This innovative approach brings vision care technology to builders worldwide, promoting accessible and convenient eye health solutions. The company's open-source project aims to improve vision care through mobile technology and digital solutions.
- Jul 2014Series A$4M
- Jun 2013Series A$2M
- Jul 2012Seed$1M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Disease Self Management coverage by sub-theme.
Regulatory-risk over time falling
Funding & growth over time
funding flat · growth flat
How research on Digital Health is moving in the United States
A read on the academic research around Digital Health — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 8,843 United States-affiliated papers.
- Design Intelligence421
- Harvard University383
- Johns Hopkins University295
- University of North Carolina at Chapel Hill206
- University of Washington173
- Health care9→240
- Wearable computer6→129
- Health informatics25→140
- Remote patient monitoring11→76
- Informatics10→60
- Health care36→766
- Health informatics113→495
- Psychological intervention20→320
- Public health34→290
- Intervention (counseling)5→193
- Health care98→1170
- Health informatics213→712
- Public health73→525
- Psychological intervention26→368
- Health administration110→363
Where digital health is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing digital health patents in the United States
United States digital health patent filing is accelerating — 2,575 filings from 1,291 assignees (2016–2025), led by Boeing, Honeywell INT, Advanced Neuromodulation Systems; annual filings 173→270.
- Boeing150
- Honeywell INT129
- Advanced Neuromodulation Systems96
- General Electric91
- Hamilton Sundstrand67
- IBM65
- OTIS Elevator50
- Sikorsky Aircraft49
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.